Taking losartan with other drugs that work in the same way may increase the chance of low blood pressure, high potassium levels in the blood, and kidney damage. NSAIDs may also reduce the blood ...

The Food and Drug Administration (FDA) has approved Arbli™, an oral suspension formulation of losartan potassium.  Arbli, an angiotensin II receptor ...

Scienture shares originally traded higher on Tuesday but have since reversed and began trading lower after the company ...

[18] The usual starting dosage of losartan potassium is 50 mg once daily. The dosage can be increased to a maximum of 100 mg daily. Doses exceeding 100 mg have not been found to produce any ...

Scienture (SCNX) announces the U.S. Food and Drug Administration, FDA, has approved SCN-102, one of the products being developed by Scienture, ...

Arbli is supplied as an peppermint-flavored oral suspension containing 10mg/mL of losartan potassium in 165mL bottles. The Food and Drug Administration (FDA) has approved Arbli ™, an oral ...

AT-II-receptor antagonists include losartan, valsartan, irbesartan, candesartan, eprosartan, telmisartan, and tasosartan. Several clinical trials have demonstrated that AT-II-receptor antagonists ...